
Thomas Regenbogen
Clinical Assistant Professor · Michigan State University
Credentials: · · · · · ·
History
- Present


- 2010–2013
Research
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia
New England Journal of Medicine · 2022 · 126 citations
Review · Journal of Thoracic Oncology · 2013 · 31 citations
Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer
Journal of Gastrointestinal Oncology · 2017 · First of 13 authors · 16 citations

1 paper

1 paper
- BT
1 paper

1 paper
- DK
1 paper
- DT
1 paper

1 paper
- EL
1 paper
